FIELD: medicine; pharmacology.
SUBSTANCE: invention claims ethers of substituted 1H-indol-3-carboxylic acid of the general formula 1 or their pharmaceutically acceptable salts. Compounds can be applied as active substance for pharmaceutical compositions and for application of these compositions in production of medicine for virus disease prevention and treatment, especially for diseases caused by infection hepatitis viruses (HCV, HBV) and influenza A viruses. In the general formula 1 R1 is aminogroup substitute selected out of hydrogen, optionally substituted inferior alkyl, optionally substituted C3-6cycloalkyl, optionally substituted aryl selected out of phenyl, naphthyl or 5-6 member heteroaryl containing 1-2 heteroatoms selected out of nitrogen, oxygen and sulfur, and possibly condensed with benzene ring of optionally substituted heterocyclyl, which can be optionally substituted 5-6-member heterocyclyl with 1-2 heteroatoms in heterocyclic ring selected out of nitrogen and oxygen; R2 is alkyl substitute selected out of hydrogen, optionally substituted hydroxyl group, optionally substituted mercapto group, optionally substituted arylsulfinyl group; optionally substituted amino group, optionally substituted 5-6-member heterocyclyl containing 1-2 heteroatoms selected out of nitrogen, oxygen and sulfur; R3 is hydrogen or optionally substituted inferior alkyl; R1 4 and R2 4 are independently substitutes of cyclic system, selected out of hydrogen or halogen atom, cyano group, trifluoromethyl, optionally substituted phenyl or optionally substituted heterocyclyl which is an optionally substituted 5-6-member heterocyclyl with 1-2 heteroatoms in heterocyclic ring, selected out of nitrogen, oxygen or sulfur, possibly condensed with benzene ring.
EFFECT: improved efficiency of compositions.
15 cl, 3 tbl, 1 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED ESTERS OF 1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING AND USING | 2006 |
|
RU2323210C9 |
SUBSTITUTED ESTERS OF 1,2,3,7-TETRAHYDROPYRROLO[3,2-f][1,3]BENZOXAZIN-5-CARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2323221C9 |
ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINING AND APPLICATION | 2007 |
|
RU2338531C1 |
SUBSTITUTED 2,3,4,5-TETRAHYDRO-1N-PYRIDO[4,3-b]INDOLES, METHOD OF OBTAINING THEM AND USE | 2007 |
|
RU2338745C1 |
ANNELATED AZAHETEROCYCLIC AMIDES, WHICH INCLUDE PYRIMIDINE FRAGMENT, METHOD OF OBTAINING AND THEIR APPLICATION | 2007 |
|
RU2345996C1 |
SUBSTITUTED 2-(5-HYDROXY-2-METHYL-1H-INDOL-3-YL)ACETIC ACIDS AND ESTERS THEREOF, ANTIVIRAL AGENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT, METHOD OF TREATING VIRAL DISEASES | 2008 |
|
RU2397975C1 |
SUBSTITUTED 4(6)-BROMINE-5-HYDROXY-1H-INDOL-3-YL ACETIC ACIDS AND ESTERS THEREOF, FOCUSED LIBRARY, ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2393149C2 |
SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2436786C1 |
ACTIVE SUBCTANCES, PHARMACEUTICAL COMPOSITION, METHOD OF THEIR PRODUCTION AND APPLICATION | 2007 |
|
RU2332421C1 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
Authors
Dates
2009-01-27—Published
2007-06-19—Filed